Skip to main content
Log in

Comparative Impact of C-Reactive Protein Testing in Hospitalized Patients with Acute Respiratory Tract Infection: A Retrospective Cohort Study

  • Original Research
  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Introduction

Evidence-based data on the usefulness of C-reactive protein (CRP) monitoring in patient outcomes are lacking. CRP testing in patients with acute respiratory tract infections (ARTIs) showed wide variability between internal medicine wards in our hospital network. In this study we aimed to investigate whether repetitive CRP tests might influence the switch of antibiotic therapy from intravenous (IV) to oral (PO) route and whether CRP measurements affect the combined outcome of readmission and in-hospital mortality.

Methods

This was a retrospective cohort study conducted in two internal medicine wards selected in a network of five teaching hospitals on the basis of their CRP prescription frequency. Clinical and laboratory data of 296 patients with ARTIs and admitted from 1 January to 31 December 2016 were analyzed.

Results

The mean ± SD of CRP tests/patient and the in-hospital length of antibiotic therapy (days) in the low-CRP (L-CRP) vs the high-CRP (H-CRP) wards were 1.14 ± 0.62 vs 3.43 ± 1.54 (p < 0.001) and 7.1 ± 2.6 vs 7.5 ± 3.2 (p = 0.298), respectively. The probability of antibiotic switching was higher in the L-CRP ward (HR 2.90, 95% CI 1.69–4.95, p < 0.001) correlating with the lower number of CRP determinations (HR 1.20, 95% CI 1.01–1.41, p = 0.034). In-hospital readmissions and mortality rates did not significantly differ between the two wards (L-CRP 17.1% vs H-CRP 10.0%, p = 0.133). The number of CRP determinations affected the combined outcome (OR 1.38, 95% CI 1.01–1.90, p = 0.043).

Conclusions

Repetitive CRP testing in ARTIs offers no added value to either antibiotic switch or patient outcomes in hospitalized patients in internal medicine wards.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. American Society of Clinical Pathology Recommendations. Choosing Wisely Campaign. http://www.choosingwisely.org. Updated February 2, 2015.

  2. Konger RL, Ndekwe P, Jones G, et al. Reduction in unnecessary clinical laboratory testing through utilization management at a US government Veterans Affairs hospital. Am J Clin Pathol. 2016;145(3):355–64.

    Article  Google Scholar 

  3. Melendez-Rosado J, Thompson KM, Cowdell JC, et al. Reducing unnecessary testing: an intervention to improve resident ordering practices. Postgrad Med J. 2017;93:476–9.

    Article  Google Scholar 

  4. Perrig M, Beck T, Wertli M, Donzé J, Rodondi N, Aujesky D. Rationale Labortests in der stationären Allgemeinen Inneren Medizin. Schweiz Ärtzteztg. 2018;99:1266–9.

    Google Scholar 

  5. American Board of Internal Medicine (ABIM) Foundation. Choosing Wisely. About the Campaign, 2015. http://www.choosingwisely.org/wpcontent/uploads/2015/04/About-Choosing-Wisely.pdf. Updated November 25, 2015.

  6. Horvath K, Semlitsch T, Jeitler K, et al. Choosing Wisely: assessment of current US top five list recommendations’ trustworthiness using a pragmatic approach. BMJ Open. 2016;6(10):e012366.

    Article  Google Scholar 

  7. Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Rinkensand PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract. 2003;53(490):358–64.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Jain S, Self WH, Wunderink RG. Community-acquired pneumonia requiring hospitalization. N Engl J Med. 2015;373(24):415–27.

    Article  CAS  Google Scholar 

  9. Erard Y, Del Giorno R, Zasa A, et al. A multi-level strategy for a long lasting reduction in unnecessary laboratory testing: a multicenter before and after study in a teaching hospital network. Int J Clin Pract. 2018;73:e13286.

    Article  Google Scholar 

  10. Ellenbogen MI, Ma M, Christensen NP, Lee J, O’Leary KJ. Differences in routine laboratory ordering between a teaching service and a hospitalist service at a single academic medical center. Southern Med. 2017;110(1):25–30.

    Article  Google Scholar 

  11. Sirovich BE, Lipner RS, Johnston M, Holmboe ES. The association between residency training and internists’ ability to practice conservatively. JAMA Intern Med. 2014;174:1640–8.

    Article  Google Scholar 

  12. Parekh V, Saint S, Furney S, Kaufman S, McMahon L. What effect does inpatient physician specialty and experience have on clinical outcomes and resource utilization on a general medical service? J Gen Intern Med. 2004;19:395–401.

    Article  Google Scholar 

  13. Lobo SM. Sequential C-reactive protein measurements in patients with serious infections: does it help? Lobo Critical Care. 2012;16:130.

    Article  Google Scholar 

  14. Bruns AHW, Oosterheert JJ, Hak E, Hoepelman AIM. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J. 2008;32:726–32.

    Article  CAS  Google Scholar 

  15. Coelho L, Pòvoa P, Almeida E, et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care. 2007;11:R92.

    Article  Google Scholar 

  16. Spegiorin Moreno M, Nietmann H, Murilo Matias C, Lobo SM. C-reactive protein: a tool in the follow-up of nosocomial pneumonia. J Infect. 2010;61(3):205–11.

    Article  Google Scholar 

  17. Almirall J, Bolibar I, Toran P, et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired penumonia. Chest. 2004;125:1335–42.

    Article  Google Scholar 

  18. Uranga A, España PP, Bilbao A, Quintana JM, Arriaga I, Intxausti M. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Internal Med. 2016;176(9):1257–65.

    Article  Google Scholar 

  19. Spellberg B. The new antibiotic mantra-“shorter is better”. JAMA Intern Med. 2016;176(9):1254–5.

    Article  Google Scholar 

  20. Alm EA, Switzer GE, Mittman BS, Walsh MBRN, Chang CCH, Fine MJ. What factors influence physicians’ decisions to switch from intravenous to oral antibiotic for community-acquired pneumonia? J Gen Intern Med. 2001;16:599–605.

    Article  Google Scholar 

  21. Dahler-Eriksen BS, Lauritzen T, Lassen JF, Lund ED, Brandslund I. Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clin Chem. 1999;45(4):478–85.

    CAS  PubMed  Google Scholar 

  22. Cals JW, Ament AJ, Hood K, et al. C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial. J Eval Clin Pract. 2011;17(6):1059–69.

    Article  Google Scholar 

  23. Oppong R, Jit M, Smith RD, et al. Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions. Br J Gen Pract. 2013;63(612):e465–71.

    Article  Google Scholar 

  24. Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10:CD007498.

    PubMed  Google Scholar 

Download references

Acknowledgments

Funding

No funding or sponsorship was received for this study or publication of this article. The Rapid Service Fee was funded by the authors. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Authorship

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Authorship Contributions

Olivier Giannini and Rosaria Del Giorno contributed equally to this work.

Disclosures

Olivier Giannini, Rosaria Del Giorno, Anna Zasa and Luca Gabutti declare that they have no conflicts of interest.

Compliance with Ethics Guidelines

The study was conducted in accordance with the Declaration of Helsinki. The study was exempt from institutional review board approval by the Swiss Ethics Committee because it involved anonymous secondary data only. Informed consent was not obtained because the data were from de-identified and previously collected administrative data.

Data Availability

The dataset analyzed during the current study is available from the corresponding author on reasonable request.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rosaria Del Giorno.

Additional information

Olivier Giannini and Rosaria Del Giorno have joint first authorship.

Enhanced Digital Features

To view enhanced digital features for this article go to https://doi.org/10.6084/m9.figshare.9761654.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giannini, O., Del Giorno, R., Zasa, A. et al. Comparative Impact of C-Reactive Protein Testing in Hospitalized Patients with Acute Respiratory Tract Infection: A Retrospective Cohort Study. Adv Ther 36, 3186–3195 (2019). https://doi.org/10.1007/s12325-019-01090-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-019-01090-6

Keywords

Navigation